<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7BE584D4-9F36-4F21-9CA7-63766CD614C6"><gtr:id>7BE584D4-9F36-4F21-9CA7-63766CD614C6</gtr:id><gtr:name>MRC Centre Oxfordshire</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BE584D4-9F36-4F21-9CA7-63766CD614C6"><gtr:id>7BE584D4-9F36-4F21-9CA7-63766CD614C6</gtr:id><gtr:name>MRC Centre Oxfordshire</gtr:name><gtr:address><gtr:line1>Harwell</gtr:line1><gtr:postCode>OX11 0RD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DF168C47-AB25-49DD-B9EC-97648F84098F"><gtr:id>DF168C47-AB25-49DD-B9EC-97648F84098F</gtr:id><gtr:firstName>Tertius</gtr:firstName><gtr:otherNames>Anton</gtr:otherNames><gtr:surname>Hough</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_13045"><gtr:id>E2742588-2ADC-473E-8AF5-4274D5A16191</gtr:id><gtr:title>High-throughput NMR metabolic profiling to enhance understanding of mammalian gene function in knockout models generated by the International Mouse Phenotyping Consortium</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_13045</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>MRC Harwell is one of the primary breeding and phenotyping centres involved in the International Mouse Phenotyping Consortium (IMPC), a world-wide consortium of institutions with capacity and expertise for large-scale primary phenotyping of the laboratory mouse. The programme aims to knock out known and predicted mouse genes to investigate the function of major organ systems in order to uncover abnormalities in various areas of human disease, and to discover and ascribe biological function to each knocked out gene by detailed primary phenotyping. The Institute of Hepatology in London supports ground-breaking research programmes into liver disease, spanning fatty liver, viral hepatitis and liver cancer. Established collaboration between MRC Harwell and the Institute of Hepatology aims to expedite the much needed development of biomarkers in liver disease. This grant funds high-throughput metabolic profiling by nuclear magnetic resonance (NMR) spectroscopy of plasma and, when available, urine from selected knockout mouse models. NMR spectroscopy is appropriate for the simultaneous and unbiased assessment of multiple metabolites, and so is ideal for documenting systemic metabolic changes attributable to the knocked-out gene. Metabolic profiling by NMR spectroscopy will enrich the existing investments made in the IMPC by increasing the depth of phenotyping and enhancing the likelihood of uncovering relevant phenotypes linked to specific metabolic pathways. The MRC Harwell plans to breed and phenotype ?105 knockout mouse lines a year for the next 5 years. Male and female knockout mice (n=7 per gender) from each line will pass through a comprehensive phenotyping pipeline along with suitable littermate and running baseline controls. The routine plasma biochemical screen include assessments of, for example liver, kidney and bone function and also provides a basic lipid profile. These investigations will be complimented by NMR spectroscopy, allowing a different perspective on identifying metabolic change in mouse lines lacking genes that could alter metabolic phenotype in an unexpected manner by detecting alterations in low molecular weight molecules. Aliquots of archived plasma from the lines started in October 2012 will be analysed retrospectively and plasma from upcoming lines analysed at the time of the routine biochemical screen. Spot urine samples from selected lines will also be analysed. NMR metabolic profiling is anticipated to be of particular importance in identifying rare diseases, which are often the result of a single gene mutation. All the IMPC phenotyping data, including the NMR spectra, will be made available in a centralised open-access database.</gtr:technicalSummary><gtr:fund><gtr:end>2014-06-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-05</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>72957</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E22193A0-2713-4DEA-B656-D557D1F4E310</gtr:id><gtr:title>&amp;sup1;H NMR metabolic profiling of plasma reveals additional phenotypes in knockout mouse models.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8e7a8027d0aecea948a6dd90260c4cc"><gtr:id>f8e7a8027d0aecea948a6dd90260c4cc</gtr:id><gtr:otherNames>Probert F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>5675e1f684d70</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_13045</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>